SBIO.L
SBIO.L
About Invesco NASDAQ Biotech UCITS ETF
The Fund is a passively managed Exchange-Traded Fund (ETF), which aims to track the Total Return performance of the NASDAQ Biotechnology Index (the Index) 1, less fees, expenses and transaction costs.
About Invesco NASDAQ Biotech UCITS ETF
The Fund is a passively managed Exchange-Traded Fund (ETF), which aims to track the Total Return performance of the NASDAQ Biotechnology Index (the Index) 1, less fees, expenses and transaction costs.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 VRTX | Vertex Pharmaceuticals Incorporated | 8.75% | - | - |
 AMGN | Amgen Inc. | 7.75% | - | - |
 GILD | Gilead Sciences, Inc. | 7.74% | - | - |
 REGN | Regeneron Pharmaceuticals, Inc. | 6.04% | - | - |
 ALNY | Alnylam Pharmaceuticals, Inc. | 4.02% | - | - |
 AZN | AstraZeneca PLC | 4.00% | - | - |
 INSM | Insmed Incorporated | 2.70% | - | - |
 BIIB | Biogen Inc. | 1.98% | - | - |
 ARGX | argenx SE | 1.73% | - | - |
 ILMN | Illumina, Inc. | 1.65% | - | - |
 INCY | Incyte Corporation | 1.56% | - | - |
 UTHR | United Therapeutics Corporation | 1.56% | - | - |
 RVMD | Revolution Medicines, Inc. | 1.43% | - | - |
 RPRX | Royalty Pharma plc | 1.27% | - | - |
 MEDP | Medpace Holdings, Inc. | 1.24% | - | - |
 ROIV | Roivant Sciences Ltd. | 1.10% | - | - |
 VTRS | Viatris Inc. | 1.03% | - | - |
 BBIO | BridgeBio Pharma, Inc. | 1.03% | - | - |
 GH | Guardant Health, Inc. | 1.02% | - | - |
 SMMT | Summit Therapeutics Inc. | 1.02% | - | - |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
United Kingdom
Netherlands
France
Ireland
Denmark
Switzerland
Germany
Canada
Singapore
Luxembourg
Spain
Australia
China
Belgium
Israel
TaiwanSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States United Kingdom Netherlands France Ireland Denmark Switzerland Germany Canada Singapore Luxembourg Spain Australia China Belgium Israel TaiwanHoldings (Top 20)
VRTX
Vertex Pharmaceuticals Incorporated
AMGN
Amgen Inc.
GILD
Gilead Sciences, Inc.
REGN
Regeneron Pharmaceuticals, Inc.
ALNY
Alnylam Pharmaceuticals, Inc.
AZN
AstraZeneca PLC
INSM
Insmed Incorporated
BIIB
Biogen Inc.
ARGX
argenx SE
ILMN
Illumina, Inc.
INCY
Incyte Corporation
UTHR
United Therapeutics Corporation
RVMD
Revolution Medicines, Inc.
RPRX
Royalty Pharma plc
MEDP
Medpace Holdings, Inc.
ROIV
Roivant Sciences Ltd.
VTRS
Viatris Inc.
BBIO
BridgeBio Pharma, Inc.
GH
Guardant Health, Inc.
SMMT
Summit Therapeutics Inc.